SCHEMBL875233

SCHEMBL875233

[CH2]CCC([CH2])NCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312843 0.72
SCHEMBL6558584 0.69
SCHEMBL1970041 0.65
SCHEMBL9228690 0.65
SCHEMBL891047 0.63
SCHEMBL4461167 0.62
SCHEMBL10617016 0.62
SCHEMBL7071831 0.61
SCHEMBL7307223 0.59
SCHEMBL580137 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329356-B2 Fungal-specific metalloproteases and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-06-25 US disclosed
US-9920320-B2 Methods of modulating compliance of the trabecular meshwork THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-03-20 US disclosed
EP-2753358-B1 FUNGAL-SPECIFIC METALLOPROTEASES AND USES THEREOF UNIV CALIFORNIA (US) 2018-01-24 EP disclosed
US-20170198060-A1 FUNGAL-SPECIFIC METALLOPROTEASES AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-07-13 US disclosed
US-9493760-B2 Fungal-specific metalloproteases and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-11-15 US disclosed
US-20160215285-A1 METHODS OF MODULATING COMPLIANCE OF THE TRABECULAR MESHWORK THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-07-28 US disclosed
US-9206423-B2 Methods of modulating compliance of the trabecular meshwork THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-12-08 US disclosed
US-20150177261-A1 DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE NILSSON JONAS (SE) 2015-06-25 US disclosed
US-8916387-B2 Diagnosis and treatment of Alzheimer's disease NILSSON JONAS (SE) 2014-12-23 US disclosed
US-20140328847-A1 MITIGATION OF DISEASE BY INHIBITION OF GALECTIN-12 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-11-06 US disclosed
WO-2007041495-A2 DAMPENING HUMORAL AND INNATE IMMUNITY BY INHIBITION OF PPGALNACT-1 UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2007-04-12 WO disclosed
WO-2005081881-A2 ANXIOLYTIC TREATMENT BY INHIBITION OF A POLYSIALYLTRANSFERASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-09-09 WO disclosed
EP-1131334-A4 USE OF CORE 2 GLCNAC TRANSFERASE INHIBITORS IN TREATING INFLAMMATION UNIV CALIFORNIA (US) 2003-05-21 EP disclosed
US-20030013636-A1 Control of immune responses by modulating activity of glycosyltransferases CYTEL CORPORATION 2003-01-16 US disclosed
US-6376475-B1 INHIBITING BIOSYNTHESIS OF SIALYL GALACTOSIDES INVOLVED IN IMMUNE RESPONSES; FOR TREATING GRAFT REJECTION, AUTOIMMUNE DISEASES, AND ALLERGIES ABARON BIOSCIENCES, INC. 2002-04-23 US disclosed
EP-1131334-A1 USE OF CORE 2 GLCNAC TRANSFERASE INHIBITORS IN TREATING INFLAMMATION The Regents of the University of California (US) 2001-09-12 EP disclosed
EP-1017846-A1 CONTROL OF IMMUNE RESPONSES BY MODULATING ACTIVITY OF GLYCOSYLTRANSFERASES CYTEL CORPORATION (US) 2000-07-12 EP disclosed
WO-2000031109-A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-06-02 WO disclosed
WO-1998054365-A1 CONTROL OF IMMUNE RESPONSES BY MODULATING ACTIVITY OF GLYCOSYLTRANSFERASES CYTEL CORPORATION (US) 1998-12-03 WO disclosed
EP-0162067-B1 PRODUCTION OF FACTOR VIII AND RELATED PRODUCTS GENETICS INSTITUTE, INC. (US) 1992-07-15 EP disclosed